(Q53517990)

English

Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.

scientific article published on 22 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

George D. Kalliolias

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

author name string

George Yiannopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

Vassilios Pastromas

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

Ioannis Antonopoulos

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

George Katsiberis

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

Stamatis-Nick Liossis

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

Andrew P Andonopoulos

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

publication date

22 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

Rheumatology International

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

27

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

357-361

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

https://scigraph.springernature.com/pub.10.1007/s00296-006-0217-1

0 references

Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High resolution computed tomography in early scleroderma lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00296-006-0217-1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17021713

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53517990&oldid=1398066695"